Correlation Between Spyre Therapeutics and SNDL

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and SNDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and SNDL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and SNDL Inc, you can compare the effects of market volatilities on Spyre Therapeutics and SNDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of SNDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and SNDL.

Diversification Opportunities for Spyre Therapeutics and SNDL

0.83

Correlation Coefficient

Spyre Therapeutics  SNDL

Very poor diversification

The 3 months correlation between Spyre and SNDL is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and SNDL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SNDL Inc and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with SNDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SNDL Inc has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and SNDL go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and SNDL

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the SNDL. In addition to that, Spyre Therapeutics is 1.61 times more volatile than SNDL Inc. It trades about -0.15 of its total potential returns per unit of risk. SNDL Inc is currently generating about -0.14 per unit of volatility. If you would invest  202.00  in SNDL Inc on October 26, 2024 and sell it today you would lose (26.00) from holding SNDL Inc or give up 12.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  SNDL Inc

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

SNDL Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SNDL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Spyre Therapeutics and SNDL

The main advantage of trading using opposite Spyre Therapeutics and SNDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, SNDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SNDL will offset losses from the drop in SNDL's long position.

The idea behind Spyre Therapeutics and SNDL Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.